Meeran K, Husain M, Puccini M, Scott H, Dionisi-Vici C, Harvey D R, Lynn J, Thakker R V
Division of Endocrinology and Metabolism, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.
Clin Endocrinol (Oxf). 1994 Oct;41(4):531-4. doi: 10.1111/j.1365-2265.1994.tb02586.x.
Neonatal primary hyperparathyroidism is a life threatening disorder that is associated with severe hypercalcaemia, hypotonia, bone demineralization, fractures and respiratory distress. Treatment consists of total parathyroidectomy and without this affected infants will usually die by the age of three months. We report a patient with neonatal primary hyperparathyroidism who survived without fractures or parathyroidectomy to an age of nine months, and in whom the hypercalcaemia became masked by vitamin D deficiency. At surgery, four-gland hyperplasia was demonstrated and total parathyroidectomy followed by oral calcitriol treatment has restored well-being and normocalcaemia. An absence of skeletal complications, a survival beyond three months of age without parathyroidectomy and the masking of the hypercalcaemia by vitamin D deficiency represents a unique combination of metabolic abnormalities in a patient with neonatal primary hyperparathyroidism.
新生儿原发性甲状旁腺功能亢进是一种危及生命的疾病,与严重高钙血症、肌张力减退、骨质脱矿、骨折和呼吸窘迫有关。治疗方法包括甲状旁腺全切术,若不进行该手术,患病婴儿通常会在三个月大时死亡。我们报告了一名患有新生儿原发性甲状旁腺功能亢进的患者,该患者在未发生骨折且未进行甲状旁腺切除术的情况下存活至九个月大,其高钙血症被维生素D缺乏所掩盖。手术时发现为四腺增生,甲状旁腺全切术后口服骨化三醇治疗使患者恢复健康并维持血钙正常。无骨骼并发症、在未进行甲状旁腺切除术的情况下存活超过三个月以及高钙血症被维生素D缺乏所掩盖,这些情况代表了一名新生儿原发性甲状旁腺功能亢进患者代谢异常的独特组合。